Gutzmer, R., Koop, A., Meier, F., & Hassel, J. C. (2017). Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity. European journal of cancer, 75, . https://doi.org/10.1016/j.ejca.2016.12.038
Chicago-Zitierstil (17. Ausg.)Gutzmer, Ralf, Anika Koop, Friedegund Meier, und Jessica C. Hassel. "Programmed Cell Death Protein-1 (PD-1) Inhibitor Therapy in Patients with Advanced Melanoma and Preexisting Autoimmunity or Pilimumab-triggered Autoimmunity." European Journal of Cancer 75 (2017). https://doi.org/10.1016/j.ejca.2016.12.038.
MLA-Zitierstil (9. Ausg.)Gutzmer, Ralf, et al. "Programmed Cell Death Protein-1 (PD-1) Inhibitor Therapy in Patients with Advanced Melanoma and Preexisting Autoimmunity or Pilimumab-triggered Autoimmunity." European Journal of Cancer, vol. 75, 2017, https://doi.org/10.1016/j.ejca.2016.12.038.